These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24648663)

  • 1. Subclassification of pulmonary non-small cell lung carcinoma in fine needle aspirates using a limited immunohistochemistry panel.
    Kapila K; Al-Ayadhy B; Francis IM; George SS; Al-Jassar A
    J Cytol; 2013 Oct; 30(4):223-5. PubMed ID: 24648663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
    Gurda GT; Zhang L; Wang Y; Chen L; Geddes S; Cho WC; Askin F; Gabrielson E; Li QK
    Clin Transl Med; 2015; 4():16. PubMed ID: 25977750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience.
    Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A
    Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
    Mukhopadhyay S; Katzenstein AL
    Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens.
    Montezuma D; Azevedo R; Lopes P; Vieira R; Cunha AL; Henrique R
    Virchows Arch; 2013 Dec; 463(6):749-54. PubMed ID: 24126803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Value of TTF-1, P63, HMWK, CK7, and CD56 Immunostaining in the Classification of Lung Carcinoma.
    Jafarian AH; Gharib M; Mohammadian Roshan N; Sherafatnia S; Omidi AA; Bagheri S
    Iran J Pathol; 2017; 12(3):195-201. PubMed ID: 29531543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
    Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
    Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
    Sethi S; Geng L; Shidham VB; Archuletta P; Bandyophadhyay S; Feng J; Madan S; Shi D; Tranchida P; Giorgadze T
    Cytojournal; 2012; 9():10. PubMed ID: 22582081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
    Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L
    Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A; Schubert PT; Koegelenberg CFN
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
    Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
    Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC; Banner B; Glickman J; Odze RD
    Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thyroid transcription factor-1 in pulmonary cytology].
    Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
    Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.